Skip to content

Effect of Honey- Ginger mouthwash on Oral Mucositis in Patients under Chemotherapy

Effect of Honey- Ginger mouthwash on Oral Mucositis in Patients under Chemotherapy in Kashan Shahid Beheshti Hospital in 2020

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130211012438N32
Enrollment
80
Registered
2020-08-23
Start date
2020-09-15
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Mucositis in Patients under Chemotherapy. Oral mucositis (ulcerative) due to antineoplastic therapy

Interventions

Intervention 1: Intervention group: the oral intervention group receives 4% ginger extract and 7% honey obtained from the Biochemistry and Nutrition Research Center of Kashan University of Medical Sci

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Having chemotherapy-induced mucositis Agree to participate in the study The patient must be at least 18 years old Patients have a definitive diagnosis of cancer (histological confirmation) Oral hygiene No history of allergies (asthma, allergic rhinitis) Patients without systemic problems weaken the immune system Absence of allergic diseases

Exclusion criteria

Exclusion criteria: Patients who received radiation therapy during the intervention Announcing the patient's non-cooperation at any stage of the project Patients who received local anesthetic during the study Use another mouthwash during the study Patients who refused to quit smoking and did not eat spicy, acidic or spicy foods. Patients with severe systemic problems (uncontrolled diabetes, advanced liver and kidney disease)

Design outcomes

Primary

MeasureTime frame
The severity of the pain. Timepoint: Before Intervention and day 7 and day14. Method of measurement: The VAS scale is given from zero to 10.;The severity of the mucositis. Timepoint: Before Intervention and day 7 and day14. Method of measurement: Based on WHO mucositis evaluation criteria.

Secondary

MeasureTime frame
. Timepoint: . Method of measurement: .

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElahe Ghasem Zade Hosseini

Kashan University of Medical Sciences

fatemee.razavii1994@gmail.com55578010

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026